Pharmabiz6h
GS1 India hosts healthcare conference on ‘Navigating the Future of Healthcare’
GS1 India, a supply chain standards organization set up under the ministry of commerce, Government of India, hosted the ...
Pharmabiz8h
BD expands capacity for advanced prefillable syringes and enhances injection experience for next generation of biologics
BD expands capacity for advanced prefillable syringes and enhances injection experience for next generation of biologics: Le ...
Pharmabiz8h
EMA’s human medicines committee elects Bruno Sepodes as new chair
EMA’s human medicines committee elects Bruno Sepodes as new chair: Amsterdam, The Netherlands Friday, September 20, 2024, ...
Pharmabiz6h
Experts urge immediate action against the growing health crisis on World Alzheimer’s Day
Experts urge immediate action against the growing health crisis on World Alzheimer’s Day: Our Bureau, Mumbai Friday, September 20, 2024, 16:45 Hrs [IST] On the occasion of World ...
Pharmabiz6h
Laurentis inks MoU with Colibri Isotopes to carry out isotopes irradiation services
Laurentis inks MoU with Colibri Isotopes to carry out isotopes irradiation services: Clarington Friday, September 20, 2024, 17:00 Hrs [IST] Laurentis Energy Partners (Laurentis) a ...
Pharmabiz7h
Bone marrow cancer drug shows success in treatment of rare blood disorder: Study
Bone marrow cancer drug shows success in treatment of rare blood disorder: Study: Bethesda, Maryland Friday, September 20, 2024, 16:00 Hrs [IST] A clinical trial supported by the ...
Pharmabiz10h
Organon to buy Dermavant Sciences including its innovative dermatologic therapy, Vtama cream 1% to treat plaque psoriasis
Basel, Switzerland Friday, September 20, 2024, 13:00 Hrs [IST] ...
Pharmabiz11h
New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients
New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...
Pharmabiz9h
ME Therapeutics to begin testing of first mRNA formulations from NanoVation Therapeutics collaboration
ME Therapeutics to begin testing of first mRNA formulations from NanoVation Therapeutics collaboration: Vancouver, British Columbia Friday, September 20, 2024, 14:00 Hrs [IST] ME ...
Pharmabiz12h
Astellas Pharma announces US FDA listing of DIGITIVA for the management of heart failure
Astellas Pharma announces US FDA listing of DIGITIVA for the management of heart failure: Tokyo Friday, September 20, 2024, 11:00 Hrs [IST] Astellas Pharma Inc. announced that DIG ...
Pharmabiz5h
InnoCare Pharma gets Chinese nod to begin clinical trial of BCL2 inhibitor ICP-248 for acute myeloid leukaemia
InnoCare Pharma gets Chinese nod to begin clinical trial of BCL2 inhibitor ICP-248 for acute myeloid leukaemia: Beijing Friday, September 20, 2024, 18:00 Hrs [IST] InnoCare Pharma ...
Pharmabiz5h
SciSparc submits IND application to US FDA for phase IIb trial for Tourette syndrome
SciSparc submits IND application to US FDA for phase IIb trial for Tourette syndrome: Tel Aviv, Israel Friday, September 20, 2024, 17:30 Hrs [IST] SciSparc Ltd., a specialty clini ...